He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Pancreatic Ductal Carcinoma Market Outlook 2025-2035: The pancreatic ductal carcinoma market is demonstrating a promising trajectory, with a projected CAGR of 5.83% across the 7 major markets between ...

New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.

A retrospective chart review was performed of patients with pancreatic cancer treated at the Johns Hopkins Hospital between January 2021 and December 2023. During their initial clinic visit, patients ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

Pancreatic cancer is one of the deadliest types of cancer, with very few people surviving for more than five years after ...

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

jhmi.edu Objective Although pancreatic ductal adenocarcinoma is considered a rapidly progressive disease, mathematical models estimate that it takes many years for an initiating pancreatic cancer cell ...